Literature DB >> 18441126

Antidepressants and suicide symptoms: compelling new insights from the FDA's analysis of individual patient level data.

Corrado Barbui1, Andrea Cipriani, John R Geddes.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18441126     DOI: 10.1136/ebmh.11.2.34

Source DB:  PubMed          Journal:  Evid Based Ment Health        ISSN: 1362-0347


× No keyword cloud information.
  5 in total

1.  Suicidal thoughts and reasons for living in hospitalized patients with severe depression: post-hoc analyses of a double-blind randomized trial of duloxetine.

Authors:  Koen Demyttenaere; Durisala Desaiah; Joel Raskin; Victoria Cairns; Stephan Brecht
Journal:  Prim Care Companion CNS Disord       Date:  2014-05-01

Review 2.  Selective serotonin reuptake inhibitors and risk of suicide: a systematic review of observational studies.

Authors:  Corrado Barbui; Eleonora Esposito; Andrea Cipriani
Journal:  CMAJ       Date:  2009-02-03       Impact factor: 8.262

Review 3.  Different regimens of intravenous sedatives or hypnotics for electroconvulsive therapy (ECT) in adult patients with depression.

Authors:  Peng Lihua; Min Su; Wei Ke; Patrick Ziemann-Gimmel
Journal:  Cochrane Database Syst Rev       Date:  2014-04-11

4.  Safety of 80 antidepressants, antipsychotics, anti-attention-deficit/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic meta-review of 78 adverse effects.

Authors:  Marco Solmi; Michele Fornaro; Edoardo G Ostinelli; Caroline Zangani; Giovanni Croatto; Francesco Monaco; Damir Krinitski; Paolo Fusar-Poli; Christoph U Correll
Journal:  World Psychiatry       Date:  2020-06       Impact factor: 49.548

Review 5.  Can systematic reviews contribute to regulatory decisions?

Authors:  Corrado Barbui; Antonio Addis; Laura Amato; Giuseppe Traversa; Silvio Garattini
Journal:  Eur J Clin Pharmacol       Date:  2017-01-07       Impact factor: 2.953

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.